| Complete Manual |
| MTN-004 SSP - All Sections | 2009-Sep-10 | 11.3 MB |
| Individual Sections |
| Overview of Sections | 2009-Sep-10 | 78.15 KB |
| Table of Contents | 2008-Aug-05 | 40.95 KB |
| Section 01 Introduction | 2009-Jun-02 | 49.89 KB |
| Section 02 Protocol | 2009-Jun-02 | 2.14 MB |
| Section 03 Documentation Requirements | 2009-Jun-02 | 237.97 KB |
| Section 04 Participant Accrual | 2009-Jun-02 | 1.07 MB |
| Section 05 Informed Consent | 2009-Jun-02 | 149.61 KB |
| Section 06 Participant Follow-Up | 2009-Jun-28 | 73.68 KB |
| Section 07 Visit Checklists | 2009-Jul-29 | 248.07 KB |
| Section 08 Participant Retention | 2008-Aug-05 | 105.03 KB |
| Section 09 Study Product Considerations for Non-Pharmacy Staff | 2008-Oct-14 | 931.2 KB |
| Section 10: Clinical Considerations | 2009-Jun-02 | 294.09 KB |
| Section 11 Adverse Event Reporting and Safety Monitoring | 2009-Sep-10 | 891.81 KB |
| Section 12 Laboratory Considerations | 2009-Jun-28 | 194.58 KB |
| Section 13 Behavioral Measures | 2009-Jun-12 | 694.76 KB |
| Section 14 Data Collection | 2009-Jun-02 | 1.52 MB |
| Section 15 Data Communiques | 2008-Jul-24 | 14.25 KB |
| Section 15: Data Communique #1 | 2008-Jul-30 | 27.62 KB |
| Section 15: Data Communique #2 | 2008-Nov-12 | 23.97 KB |
| Section 15: Data Communique #3 | 2009-Jul-27 | 23.44 KB |
| Section 16 Study Reporting Plan | 2009-Jun-02 | 24.94 KB |
